3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:千円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年2月28日)

当連結会計年度

(2026年2月28日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

6,768,998

6,121,536

 

 

受取手形

7,439

11,410

 

 

売掛金

7,478,539

8,361,680

 

 

商品

2,215,859

2,361,345

 

 

その他

1,500,685

2,300,691

 

 

貸倒引当金

6,487

10,254

 

 

流動資産合計

17,965,034

19,146,409

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

13,676,578

14,555,807

 

 

 

 

減価償却累計額

7,687,419

8,055,746

 

 

 

 

建物及び構築物(純額)

5,989,158

6,500,060

 

 

 

車両運搬具

141,377

132,530

 

 

 

 

減価償却累計額

97,863

86,054

 

 

 

 

車両運搬具(純額)

43,513

46,475

 

 

 

工具、器具及び備品

1,762,562

1,932,016

 

 

 

 

減価償却累計額

1,465,575

1,552,246

 

 

 

 

工具、器具及び備品(純額)

296,987

379,770

 

 

 

土地

3,588,121

3,847,313

 

 

 

建設仮勘定

124,233

132,475

 

 

 

有形固定資産合計

10,042,014

10,906,096

 

 

無形固定資産

 

 

 

 

 

のれん

816,413

774,657

 

 

 

その他

173,199

162,630

 

 

 

無形固定資産合計

989,612

937,288

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

2,405,444

3,316,934

 

 

 

繰延税金資産

521,054

517,237

 

 

 

敷金及び保証金

1,167,481

1,052,460

 

 

 

その他

1,141,133

1,646,987

 

 

 

投資その他の資産合計

5,235,113

6,533,619

 

 

固定資産合計

16,266,740

18,377,004

 

資産合計

34,231,775

37,523,413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:千円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年2月28日)

当連結会計年度

(2026年2月28日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形

6,414

994

 

 

買掛金

5,440,590

5,755,710

 

 

電子記録債務

625,034

674,767

 

 

短期借入金

1,180,000

530,000

 

 

1年内返済予定の長期借入金

2,609,852

2,281,353

 

 

未払法人税等

535,143

374,104

 

 

賞与引当金

266,885

307,236

 

 

その他

1,004,744

1,693,506

 

 

流動負債合計

11,668,666

11,617,672

 

固定負債

 

 

 

 

社債

-

150,000

 

 

長期借入金

6,052,443

7,252,962

 

 

リース債務

175,552

150,105

 

 

退職給付に係る負債

1,100,344

1,086,186

 

 

その他

522,634

980,672

 

 

固定負債合計

7,850,975

9,619,926

 

負債合計

19,519,641

21,237,598

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

917,000

917,000

 

 

資本剰余金

1,085,044

1,064,347

 

 

利益剰余金

12,391,773

12,797,102

 

 

自己株式

531,724

7,129

 

 

株主資本合計

13,862,094

14,771,321

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

232,084

802,886

 

 

退職給付に係る調整累計額

3,682

57,907

 

 

その他の包括利益累計額合計

235,766

860,793

 

非支配株主持分

614,273

653,700

 

純資産合計

14,712,134

16,285,814

負債純資産合計

34,231,775

37,523,413

 

E03443 33530 株式会社メディカル一光グループ Medical Ikkou Group Co.,Ltd. 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-03-01 2026-02-28 FY 2026-02-28 2024-03-01 2025-02-28 2025-02-28 1 false false false 33530 2026-04-06 33530 2025-03-01 2026-02-28 33530 2025-03-01 2026-02-28 jppfs_cor:CapitalStockMember 33530 2025-03-01 2026-02-28 jppfs_cor:CapitalSurplusMember 33530 2025-03-01 2026-02-28 jppfs_cor:NonControllingInterestsMember 33530 2025-03-01 2026-02-28 jpcrp_cor:ReconcilingItemsMember 33530 2025-03-01 2026-02-28 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 33530 2025-03-01 2026-02-28 jppfs_cor:RetainedEarningsMember 33530 2025-03-01 2026-02-28 jppfs_cor:ShareholdersEquityMember 33530 2025-03-01 2026-02-28 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 33530 2025-03-01 2026-02-28 jppfs_cor:TreasuryStockMember 33530 2025-03-01 2026-02-28 tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember 33530 2025-03-01 2026-02-28 tse-acedjpfr-33530:HealthCareReportableSegmentsMember 33530 2025-03-01 2026-02-28 tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember 33530 2025-03-01 2026-02-28 tse-acedjpfr-33530:RealEstateReportableSegmentsMember 33530 2025-03-01 2026-02-28 jpcrp_cor:UnallocatedAmountsAndEliminationMember 33530 2025-03-01 2026-02-28 jppfs_cor:ValuationAndTranslationAdjustmentsMember 33530 2025-03-01 2026-02-28 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 33530 2026-02-28 33530 2026-02-28 jppfs_cor:CapitalStockMember 33530 2026-02-28 jppfs_cor:CapitalSurplusMember 33530 2026-02-28 jppfs_cor:NonControllingInterestsMember 33530 2026-02-28 jpcrp_cor:ReconcilingItemsMember 33530 2026-02-28 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 33530 2026-02-28 jppfs_cor:RetainedEarningsMember 33530 2026-02-28 jppfs_cor:ShareholdersEquityMember 33530 2026-02-28 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 33530 2026-02-28 jppfs_cor:TreasuryStockMember 33530 2026-02-28 tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember 33530 2026-02-28 tse-acedjpfr-33530:HealthCareReportableSegmentsMember 33530 2026-02-28 tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember 33530 2026-02-28 tse-acedjpfr-33530:RealEstateReportableSegmentsMember 33530 2026-02-28 jpcrp_cor:UnallocatedAmountsAndEliminationMember 33530 2026-02-28 jppfs_cor:ValuationAndTranslationAdjustmentsMember 33530 2026-02-28 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 33530 2024-03-01 2025-02-28 33530 2024-03-01 2025-02-28 jppfs_cor:CapitalStockMember 33530 2024-03-01 2025-02-28 jppfs_cor:CapitalSurplusMember 33530 2024-03-01 2025-02-28 jppfs_cor:NonControllingInterestsMember 33530 2024-03-01 2025-02-28 jpcrp_cor:ReconcilingItemsMember 33530 2024-03-01 2025-02-28 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 33530 2024-03-01 2025-02-28 jppfs_cor:RetainedEarningsMember 33530 2024-03-01 2025-02-28 jppfs_cor:ShareholdersEquityMember 33530 2024-03-01 2025-02-28 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 33530 2024-03-01 2025-02-28 jppfs_cor:TreasuryStockMember 33530 2024-03-01 2025-02-28 tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember 33530 2024-03-01 2025-02-28 tse-acedjpfr-33530:HealthCareReportableSegmentsMember 33530 2024-03-01 2025-02-28 tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember 33530 2024-03-01 2025-02-28 tse-acedjpfr-33530:RealEstateReportableSegmentsMember 33530 2024-03-01 2025-02-28 jpcrp_cor:UnallocatedAmountsAndEliminationMember 33530 2024-03-01 2025-02-28 jppfs_cor:ValuationAndTranslationAdjustmentsMember 33530 2024-03-01 2025-02-28 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 33530 2025-02-28 33530 2025-02-28 jppfs_cor:CapitalStockMember 33530 2025-02-28 jppfs_cor:CapitalSurplusMember 33530 2025-02-28 jppfs_cor:NonControllingInterestsMember 33530 2025-02-28 jpcrp_cor:ReconcilingItemsMember 33530 2025-02-28 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 33530 2025-02-28 jppfs_cor:RetainedEarningsMember 33530 2025-02-28 jppfs_cor:ShareholdersEquityMember 33530 2025-02-28 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember 33530 2025-02-28 jppfs_cor:TreasuryStockMember 33530 2025-02-28 tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember 33530 2025-02-28 tse-acedjpfr-33530:HealthCareReportableSegmentsMember 33530 2025-02-28 tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember 33530 2025-02-28 tse-acedjpfr-33530:RealEstateReportableSegmentsMember 33530 2025-02-28 jpcrp_cor:UnallocatedAmountsAndEliminationMember 33530 2025-02-28 jppfs_cor:ValuationAndTranslationAdjustmentsMember 33530 2025-02-28 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 33530 2024-02-29 33530 2024-02-29 jppfs_cor:CapitalStockMember 33530 2024-02-29 jppfs_cor:CapitalSurplusMember 33530 2024-02-29 jppfs_cor:NonControllingInterestsMember 33530 2024-02-29 jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember 33530 2024-02-29 jppfs_cor:RetainedEarningsMember 33530 2024-02-29 jppfs_cor:ShareholdersEquityMember 33530 2024-02-29 jppfs_cor:TreasuryStockMember 33530 2024-02-29 jppfs_cor:ValuationAndTranslationAdjustmentsMember 33530 2024-02-29 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure